Table II.
Sarcoidosis and control BAL demographics and immunophenotype
| Diagnosis | Race | Sex | Scadding stage | Extrapulmonary disease | Imunosuppression | Macrophages | Lymphocytes | PMN | Eos | CD4/CD8 ratio | Th17 cell frequency | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sarcoidosis 1 | Sarcoidosis | AA | M | 3 | No | No | 79 | 22 | 0 | 0 | 1.23 | 1.17 |
| Sarcoidosis 2 | Sarcoidosis | C | M | 1 | No | No | 92 | 4 | 4 | 0 | ND | 1.13 |
| Sarcoidosis 3 | Sarcoidosis | C | M | 2 | No | No | 97 | 2 | 1 | 0 | 0.57 | 2.37 |
| Sarcoidosis 4 | Sarcoidosis | AA | F | 1 | Ocular | no | 84 | 16 | 0 | 0 | 4.94 | 0.99 |
| Sarcoidosis 5 | Sarcoidosis | AA | M | 1 | CNS | Azathioprine | 96 | 3 | 1 | 0 | 1.29 | 0.44 |
| Sarcoidosis 6 | Sarcoidosis | C | F | 1 | No | No | 83 | 15 | 1 | 1 | 6.08 | 0.23 |
| Sarcoidosis 7 | Sarcoidosis | C | F | 1 | CNS | No | 86 | 1 | 2 | 0 | 3.32 | 0.08 |
| Sarcoidosis 8 | Sarcoidosis | C | M | 1 | No | ND | 50 | 43 | 6 | 1 | 22 | 0.6 |
| Sarcoidosis 9 | Sarcoidosis | C | F | 3 | Cardiac | ND | 80 | 1 | 10 | 0 | ND | 0.8 |
| Sarcoidosis 10 | Sarcoidosis Alveolar | C | F | 2 | No | No | 4 | 4 | 89 | 3 | ND | 1.11 |
| Control 1 | Hemorrhage | C | M | No | 87 | 13 | 0 | 0 | 1.45 | 0.28 | ||
| Control 2 | Hemosiderosis | C | F | No | 91 | 2 | 1 | 0 | 0.4 | 0.35 | ||
| Control 3 | Undefined ILD | C | M | Prednisone | 85 | 2 | 13 | 0 | 0.32 | 0.22 | ||
| Control 4 | RBILD | C | M | No | 100 | 0 | 0 | 0 | 0.19 | 0.39 | ||
| Control 5 | RBILD | C | F | No | 99 | 0 | 1 | 0 | 0.18 | 0.34 |
AA African-American, C Causasian, M Male, ILD Interstitial Lund Disease, RBILD Right Brochiolitis ILD, ND Not determined, CNS Central nervous System